Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising incidence of Cancer Worldwide
4.2.2 Growing Government Initiatives for Cancer Awareness
4.3 Market Restraints
4.3.1 High Cost of Cancer Therapies
4.3.2 Dearth of Skilled Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product & Service
5.1.1 Software
5.1.2 Service
5.2 By Application
5.2.1 Medical Oncology
5.2.2 Radiation Oncology
5.2.3 Surgical Oncology
5.3 By End User
5.3.1 Hospitals
5.3.2 Research Centers
5.3.3 Specialty Clinics
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Cerner Corporation
6.1.2 Varian Medical Systems
6.1.3 Elekta AB
6.1.4 CureMD Corporation
6.1.5 McKesson Corporation
6.1.6 Flatiron Health, Inc.
6.1.7 Accuray Incorporated
6.1.8 RaySearch Laboratories AB
6.1.9 BMSI Partners, Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS